Search Results

Filter
  • 1-4 of  4 results for ""Non-Muscle Invasive Bladder Neoplasms""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Is switching intravesical chemotherapeutic agents beneficial in short-term recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective study.

  • Authors : Chen S; Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.; Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.

Subjects: Non-Muscle Invasive Bladder Neoplasms*/Non-Muscle Invasive Bladder Neoplasms*/Non-Muscle Invasive Bladder Neoplasms*/drug therapy ; Non-Muscle Invasive Bladder Neoplasms*/Non-Muscle Invasive Bladder Neoplasms*/Non-Muscle Invasive Bladder Neoplasms*/surgery ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy

  • Source: BMC urology [BMC Urol] 2024 Jan 31; Vol. 24 (1), pp. 25. Date of Electronic Publication: 2024 Jan 31.Publisher: BioMed Central Country of Publication: England NLM ID: 100968571 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2490

Record details

×
Academic Journal

Nomogram for customized recurrence prediction in primary non-muscle-invasive bladder cancer based on routine blood and urine parameters.

  • Authors : He Y; Department of Urology, the Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.; Pan C

Subjects: Non-Muscle Invasive Bladder Neoplasms* ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/pathology; Humans

  • Source: BMC urology [BMC Urol] 2024 Mar 25; Vol. 24 (1), pp. 67. Date of Electronic Publication: 2024 Mar 25.Publisher: BioMed Central Country of Publication: England NLM ID: 100968571 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2490

Record details

×
Academic Journal

Guidance of adjuvant instillation in intermediate-risk non-muscle invasive bladder cancer by drug screens in patient derived organoids: a single center, open-label, phase II trial.

  • Authors : Seiler R; Department of Urology, Hospital Center Biel, Spitalzentrum Biel, Vogelsang 84, 2501, Biel, Switzerland. .; Department for BioMedical Research, Translational Organoid Resource Core, University of Bern, Bern, Switzerland. .

Subjects: Non-Muscle Invasive Bladder Neoplasms* ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/surgery; Humans

  • Source: BMC urology [BMC Urol] 2023 May 11; Vol. 23 (1), pp. 89. Date of Electronic Publication: 2023 May 11.Publisher: BioMed Central Country of Publication: England NLM ID: 100968571 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2490

Record details

×
Academic Journal

Evaluation of serum fibronectin levels and fibronectin gene polymorphism in patients receiving intravesical BCG therapy for non-muscle invasive bladder cancer and its prognostic value.

  • Authors : Nebioğlu A; Department of Urology, Mersin City Training and Research Hospital, Korukent Mah. 96015 St. Mersin Integrated Health Campus, Toroslar, Mersin, 33240, Turkey. .; Tanrıverdi R

Subjects: Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/blood ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/genetics

  • Source: BMC urology [BMC Urol] 2024 Sep 28; Vol. 24 (1), pp. 210. Date of Electronic Publication: 2024 Sep 28.Publisher: BioMed Central Country of Publication: England NLM ID: 100968571 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2490

Record details

×
  • 1-4 of  4 results for ""Non-Muscle Invasive Bladder Neoplasms""